In the co‐culture of IR‐LX2 CM‐stimulated THP‐1 CM and IR‐HCC cells, CCL20 neutralising antibody, CCR6 inhibitor or JSH‐23 treatment had no significant effect on CCL5 production (Figure S10C). Here, CCR6 is linked to hepatocellular carcinoma.